In particular, factors that have already proven their usefulness in related clinical settings of endothelial dysfunction are of interest, such as the modulation of vascular endothelial growth factor (VEGF) levels in patients with renal failure undergoing hemodialysis (HD) or peritoneal dialysis (PD) [8,15]. The gene discussed is VEGFA; the disease is acute kidney injury.